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The abbreviations used are: 
+TIP Plus-end tracking microtubule-associated protein  
AcK40 -tubulin lysine 40 acetylation 
AGAP3 Arf-GAP with GTPase, ANK repeat, and PH domain-containing protein 3 
ANK ankyrin 
AP-MS affinity purification coupled with mass spectrometry 
BAS basal 
CAP-Gly cytoskeleton-associated protein Gly-rich 
CKAP5 cytoskeleton-associated protein 5 
CLASP1 CLIP-associating protein 1 
CLASP2 CLIP-associating protein 2 
CLIP1/CLIP-170 CAP-Gly domain-containing linker protein 1 
CLIP2/CLIP-115 CAP-Gly domain-containing linker protein 2 
co-IP(s) co-immunoprecipitation(s) 
CTCF corrected total cell fluorescence  
CTRL control 
EB1 end binding protein 1 
EB3 end binding protein 3 
EBH EB homology 
EEY/F EEY/F motif 
FA formic acid 
GAP GTPase-activating protein 
GAR Gas2-related 
GAS2 growth-arrest-specific 2  
GAS2L1/G2L1 GAS2 like protein 1 
GFP green fluorescent protein 
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GLD GTP-binding protein-like domain 
GLUT4 solute carrier family 2, facilitated glucose transporter member 4 





KA1 kinase associated domain 1 
MAP microtubule associated protein 
MARK2 microtubule affinity-regulating kinase 2 
MK protein ladder marker 
MS/MS tandem mass spectrometry 
NIgG non-immune serum 
NOCO nocodazole 
PH pleckstrin homology 
P-Score probability score 
ROI region of interest 
SAINT significance analysis of interactome 
SB SB216763 
SC spectrum count  
SCP spectrum count profile 
SD standard deviation 
SEM standard error of the mean 
TOG tumor overexpressed gene 









 Insulin-stimulated glucose uptake is known to involve microtubules, although the function 
of microtubules and the microtubule-regulating proteins involved in insulin action are poorly 
understood. CLASP2, a plus-end tracking microtubule-associated protein (+TIP) that controls 
microtubule dynamics, was recently implicated as the first +TIP associated with insulin-regulated 
glucose uptake. Here, using protein-specific targeted quantitative phosphoproteomics within 3T3-
L1 adipocytes, we discovered that insulin regulates phosphorylation of the CLASP2 network 
members G2L1, MARK2, CLIP2, AGAP3 and CKAP5 as well as EB1, revealing the existence of 
a previously unknown microtubule-associated protein system that responds to insulin. To further 
investigate, G2L1 interactome studies within 3T3-L1 adipocytes revealed that G2L1 co-
immunoprecipitates CLASP2 and CLIP2 as well as the master integrators of +TIP assembly, the 
end binding (EB) proteins. Live-cell total internal reflection fluorescence microscopy in adipocytes 
revealed G2L1 and CLASP2 colocalize on microtubule plus-ends. We found that while insulin 
increases the number of CLASP2-containing plus-ends, insulin treatment simultaneously 
decreases CLASP2-containing plus-end velocity. In addition, we discovered that insulin 
stimulates re-distribution of CLASP2 and G2L1 from exclusive plus-end tracking to “trailing” 
behind the growing tip of the microtubule. Insulin treatment increases -tubulin Lysine 40 
acetylation, a mechanism that was observed to be regulated by a counterbalance between GSK3 
and mTOR, and also led to microtubule stabilization. Our studies introduce insulin-stimulated 
microtubule stabilization and plus-end trailing of +TIPs as new modes of insulin action and reveal 
the likelihood that a network of microtubule-associated proteins synergize to coordinate insulin-





 Since the initial discovery of insulin-stimulated cytoskeletal remodelling over 25 years ago 
(1), the role of both actin and microtubule reorganization in insulin action and the proteins that 
regulate these processes have been the subject of investigation. Upon insulin stimulation, cell 
models of insulin target tissues including 3T3- L1 adipocytes as well as L6 and C2C12 myotubes 
(2-6) exhibit profound actin reorganization at the plasma membrane as a result of actin branching. 
Rac1 is a master regulator of actin dynamics and inhibiting either Rac1 or Rac1-effector proteins 
severely diminishes trafficking of the insulin responsive glucose transporter (Solute carrier family 
2, facilitated glucose transporter member 4 or “GLUT4”) and subsequent insulin-stimulated 
glucose uptake (7). Therefore, insulin not only relies on signal transduction through protein-protein 
communication, but also requires a specific cytoskeletal environment to properly enhance acute 
glucose uptake. Studies characterizing the proteins involved in insulin-controlled actin regulation 
have been more prevalent than those focused on proteins involved in regulating microtubule 
dynamics upon insulin stimulation. As a result, much more progress has been made on 
elucidating the actin system under insulin control versus that of microtubules. 
Microtubules possess the unique characteristic of “dynamic instability”, their growth and 
shrinkage serve as modes of functional regulation across a multitude of molecular platforms. 
Microtubule assembly and disassembly rates as well as duration of stability are controlled in part 
by “microtubule-associated proteins” (MAPs), a large family of proteins with several notable sub-
groups (reviewed in (8)). While many of the MAPs localize at the base of the microtubule (the 
minus-end) or along the length of the microtubules (the lattice), the plus-end tracking proteins 
(+TIPs) are found at the growing tip of the microtubule (the plus-end). The +TIPs are a functionally 
diverse group of almost 20 proteins, and as such, their regulation and cooperativity have been 
explored at length (reviewed in (9)), although not in the context of insulin action. One exception 
is CLIP-associating protein 2 (CLASP2) (10), a +TIP that was found to be enriched in an unbiased 
proteomics screen for proteins that undergo insulin-stimulated phosphorylation (11). Just like the 
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rest of the +TIPs, CLASP2 tracks the plus-end of microtubules, associates with an assortment of 
other +TIPs, and is involved in a variety of microtubule-regulated cellular events (12). Notably, 
CLASP2 has been linked to the “search and capture” behaviour of microtubules (13), wherein 
microtubule tips are observed to seek out specific landing zones through CLASP2 binding of 
proteins localized at particular subcellular regions (14-18). For example, CLASP2 binding to 
microtubule capture sites on the cell cortex creates a delivery route for acetylcholine receptors to 
neuromuscular junctions (19) as well as exocytotic vesicles traveling to focal adhesions (20). 
These observations revealed that under certain cellular contexts, microtubules adopt specific 
patterns of reorganization which possess both temporal and spatial characteristics that 
synchronize with +TIP function.  
Microtubules and actin routinely cooperate through proteins including the formins (21), the 
spectraplakins (22), and members of the growth-arrest-specific 2 (GAS2) family (23). One of the 
GAS2 family members, G2L1, was recently discovered in the CLASP2 interactome in 3T3-L1 
adipocytes (24). G2L1 interacts with both actin and microtubules to coordinate actin and 
microtubule alignment (23, 25, 26), an event that is of potential interest within insulin action since 
the insulin-responsive GLUT4 storage vesicle has been proposed to switch tracks at an interface 
between microtubules and actin at the plasma membrane (27).  
Early immunofluorescence studies coupled with biochemical techniques first discovered 
that insulin increases tubulin polymerization in 3T3-L1 adipocytes (28). A decade later, using live-
cell total internal reflection fluorescence (TIRF) microscopy, it was demonstrated that insulin 
increases microtubule density and curvature in the 200nm immediately proximal to the plasma 
membrane in 3T3-L1 adipocytes (29). The purpose of these dynamic microtubule events has 
never been established and the mechanisms underlying microtubule regulation in insulin action 
are still unknown. This report presents new findings that significantly expand the number of +TIPs 
affected by insulin, evidence for the existence of an undiscovered microtubule-associated protein 
system under insulin control. We found that insulin stimulation promotes a re-distribution of 
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CLASP2 and G2L1 from exclusive microtubule plus-end localization to “trailing” behind the 
growing tip of the microtubule along the microtubule lattice. We discovered that insulin acutely 
stimulates acetylation of -tubulin at Lysine 40 and promotes microtubule stabilization, a 
phenomenon never before linked to acute insulin action. Our studies introduce a new insulin-
responsive protein system as well as novel insulin-regulated microtubule and microtubule-
associated protein dynamics, findings that significantly expand our understanding of the 
relationship between insulin and the microtubule network. 
   
EXPERIMENTAL PROCEDURES  
Cell Culture, Immunoprecipitation, and Western Blot Analysis. Mouse 3T3-L1 fibroblasts 
were differentiated into adipocytes exactly as previously described (24). For cell treatment 
experiments, cells were starved for four hours in serum free media containing 0.3% BSA and then 
either left untreated or stimulated with 100 nM insulin for 15 min (unless otherwise indicated) at 
37 °C. Cells were lysed with 500 L of lysis buffer containing 40 mM HEPES (pH 7.6), 120 mM 
NaCl, 0.3% CHAPS, 10 mM NaF, 10 mM β-glycerol phosphate, 1 mM EDTA (pH 8.0), 2 mM 
sodium orthovanadate, 17 µg/ml aprotinin, 10 µg/ml leupeptin, and 1 mM PMSF. Cell lysates were 
rotated at 4 °C for 20 min followed by centrifugation (14,000 RPM, 4 °C, 20 min), and the clarified 
supernatants were used for immunoprecipitation (IP). IPs and preparation for SDS-PAGE were 
performed exactly as previously described (24). The eluates were separated by 10% SDS-PAGE 
and the gels were either stained with Bio-Safe Coomassie G-250 Stain (Bio-Rad, Hercules, CA) 
or transferred to a nitrocellulose membrane for subsequent western blotting. Western blots were 
performed exactly as previously described (24). Primary antibodies used: anti-G2L1 (cat. # 
H00010634-B01P, Novus Biologicals, Littleton, CO), anti-mCherry (cat. # NBP2-43720, Novus 
Biologicals), anti-myc (cat. # 2276, Cell Signaling Technologies, Danvers, MA), anti-EB1 (cat # 
E3406, Sigma-Aldrich, St. Louis, MO), anti--tubulin (cat. # T9026, Sigma-Aldrich), anti-
acetylated Lysine 40 of -tubulin (“AcK40”) (cat. # 5335, Cell Signaling Technologies), anti-
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MARK2 (cat. # NBP1-71890, Novus Biologicals), anti-CLIP2 (cat. # SAB1412760, Sigma Aldrich), 
anti-AGAP3 (cat. # SAB2700915, Sigma Aldrich), and anti-CKAP5 (cat. # 620401, Biolegend). 
In-gel Digestion. Proteins were separated by SDS-PAGE and stained with Bio-Safe 
Coomassie G-250 Stain. For the interactome experiments, each lane of the SDS-PAGE gel was 
cut into seven slices. For the specific protein targeted phosphoproteomics experiments, the single 
band corresponding to the location of the individual protein on the SDS-PAGE gel was excised. 
The gel slices were subjected to trypsin digestion and the resulting peptides were purified by C18-
based desalting exactly as previously described (24). The dried peptides were resuspended in 6 
l of 0.1% FA (v/v) followed by sonication for 2 min. 2.5 l of the final sample was then analyzed 
by mass spectrometry. 
Mass Spectrometry and Spectrum Count Data Processing. HPLC-ESI-MS/MS was 
performed in positive ion mode on a Thermo Scientific Orbitrap Fusion Lumos tribrid mass 
spectrometer fitted with an EASY-Spray Source (Thermo Scientific, San Jose, CA). NanoLC was 
performed without a trap column using a Thermo Scientific UltiMate 3000 RSLCnano System with 
an EASY Spray C18 LC column (Thermo Scientific, 50cm x 75 μm inner diameter, packed with 
PepMap RSLC C18 material, 2 µm, cat. # ES803); loading phase for 15 min at 0.300L/min; 
mobile phase, linear gradient of 1–34% Buffer B in 119 min at 0.220 L/min, followed by a step 
to 95% Buffer B over 4 min at 0.220 L/min, hold 5 min at 0.250 L/min, and then a step to 1% 
Buffer B over 5 min at 0.250 L/min and a final hold for 10 min (total run 159 min); Buffer A = 
0.1% FA/H2O; Buffer B = 0.1% FA in 80% ACN. All solvents were liquid chromatography mass 
spectrometry grade. Spectra were acquired using XCalibur, version 2.3 (Thermo Scientific). A 
“top speed” data-dependent MS/MS analysis was performed. Dynamic exclusion was enabled 
with a repeat count of 1, a repeat duration of 30 sec, and an exclusion duration of 60 sec. Tandem 
mass spectra were extracted from Xcalibur ‘RAW’ files and charge states were assigned using 
the ProteoWizard 3.0.1 msConvert script using the default parameters (30). The fragment mass 
10 
 
spectra were then searched against the mouse SwissProt_2016_10 database (23,550 entries) 
using Mascot (Matrix Science, London, UK; version 2.4) using the default probability cut-off score. 
The search variables that were used were: 10 ppm mass tolerance for precursor ion masses and 
0.5 Da for product ion masses; digestion with trypsin; a maximum of two missed tryptic cleavages; 
variable modifications of oxidation of methionine and phosphorylation of serine, threonine, and 
tyrosine. Cross-correlation of Mascot search results with X! Tandem was accomplished with 
Scaffold (version Scaffold_4.8.7; Proteome Software, Portland, OR, USA). Probability 
assessment of peptide assignments and protein identifications were made through the use of 
Scaffold. Only peptides with ≥ 95% probability were considered. Reported peptide FDR rates from 
Scaffold ranged from 0.1-0.2%. The mass spectrometry proteomics data have been deposited to 
the ProteomeXchange Consortium via the PRIDE partner repository (31) with the dataset 
identifier PXD011431 and 10.6019/PXD011431. For the Spectrum Count Profiles, the Uniprot IDs 
are listed. 
Label-free Quantitative Proteomics. Progenesis QI for proteomics software (version 2.4, 
Nonlinear Dynamics Ltd., Newcastle upon Tyne, UK) was used to perform ion-intensity based 
label-free quantification. In brief, in an automated format, .raw files were imported and converted 
into two-dimensional maps (y-axis = time, x-axis =m/z) followed by selection of a reference run 
for alignment purposes. An aggregate data set containing all peak information from all samples 
was created from the aligned runs, which was then further narrowed down by selecting only +2, 
+3, and +4 charged ions for further analysis. The samples were then grouped in basal versus 
insulin. A peak list of fragment ion spectra from only the top eight most intense precursors of a 
feature was exported in Mascot generic file (.mgf) format and searched against the mouse 
SwissProt_2016_10 (23,550 entries) database using Mascot (Matrix Science, London, UK; 
version 2.4). The search variables that were used were: 10 ppm mass tolerance for precursor ion 
masses and 0.5 Da for product ion masses; digestion with trypsin; a maximum of two missed 
tryptic cleavages; variable modifications of oxidation of methionine and phosphorylation of serine, 
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threonine, and tyrosine; 13C=1. The resulting Mascot .xml file was then imported into Progenesis, 
allowing for peptide/protein assignment, while peptides with a Mascot Ion Score of <25 were not 
considered for further analysis. Precursor ion-abundance values for specific phosphopeptide ions 
were normalized to a selected series of standard peptide ions for the same target protein. The 
selected series of standard peptide ions had to conform to a set of rules previously established 
(32-34), i.e. (1) detected by HPLC-ESI-MS with high intensity among the peptides for the target 
protein; (2) no missed cleavage observed; (3) no methionine in the sequence to avoid variability 
due to methionine oxidization and no N-terminal Gln residues; (4) cannot be a non-
phosphorylated version of a peptide that was detected as being phosphorylated. Each 
phosphopeptide ion’s normalized abundance value was normalized by the mean value of the 
respective basal sample and then expressed as a fold change over basal ±SEM. When multiple 
peptide ions were present for a particular phosphopeptide ion, a representative peptide ion was 
chosen to reflect the effect of insulin. For the proof of principle dose curve test, no normalization 
was performed. 
Generation of Viruses and transduction of 3T3-L1 Adipocytes. Negative control null GFP 
adenovirus as well as N-terminal GFP plus C-terminal HA-tagged mouse CLASP2 adenovirus 
were described before (24). Negative control null mCherry adenovirus as well as N-terminal 
mCherry plus C-terminal myc-tagged mouse G2L1 adenovirus using G2L1 cDNA, cat. # 
MC204613 from Origene (Rockville, MD) were created by VECTOR BIOLABS (Malvern, PA). 
Viral infections were performed on 150 mm plates of 3T3-L1 adipocytes as previously described 
(24). Lentiviral transfer plasmid pCIG3 (Addgene #78264, a gift from Felicia Goodrum) was 
modified to express a puromycin resistance gene in place of GFP. mRuby2-Tubulin-6 (human 
Tubulin alpha 1b; Addgene #55914, a gift from Michael Davidson) was subcloned into this 
backbone by addition of the restriction sites KpnI and BamHI by PCR, to generate pLenti-
mRuby2-Tubulin. To generate pLenti-iRFP670-Tubulin, tubulin was first subcloned out of the 
mRuby2-Tubulin-6 vector and into piRFP670-N1 (Addgene #45457, a gift from Vladislav 
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Verkhusha). iRFP670-Tubulin was then subcloned out of the piRFP670-Tubulin vector and into 
the pLenti backbone to generate pLenti-iRFP670-Tubulin. Second generation lentiviral particles 
were generated by PEI transfection of 293T cells as previously described (35) with transfer 
plasmid, pMD2.G, and psPAX2 (Addgene #12259, #12260, gifts from Didier Trono). At 48 and 72 
hours post-transfection, 293T media containing lentiviral particles was collected and combined 
followed by centrifugation at 500 x g for 15 minutes. The supernatant was filtered and either 
immediately used or concentrated (Lenti Concentrator, cat. # TR30025, Origene), depending on 
the virus. The virus was added directly to adipocyte cultures with polybrene. The following day, 
cells were split onto Poly-D-Lysine (cat. # A-003-E, Sigma Aldrich) treated glass bottom dishes 
(cat. # P35GCol-1.5-14-C, MatTek Corporation), and the cells were imaged 24 hours later. 
Immunofluorescence and Live-Cell Imaging. For live-cell imaging experiments, cells were 
cultured on No. 1.5 coverslip bottom dishes (Mattek, Ashland, MA). Adipocytes were starved for 
one hour in serum free media containing 0.3% BSA and then either left untreated or stimulated 
with 100 nM insulin for the indicated duration at 37 °C. For immunofluorescence studies, 3T3-L1 
adipocytes were split onto coverslips (cat. # 1254580, Fisher Scientific). The following day, the 
cells were starved for 4 hours in serum free media containing 0.3% BSA followed by the indicated 
cell treatments. Cells were fixed with 100%, -20 °C methanol for 20 minutes followed by 
permeabilization with 1% Tween-20 and 2% PFA. The background signal was quenched with 0.1 
M glycine followed by incubation in 1% BSA. Coverslips were incubated with anti-α-Tubulin and 
anti-AcK40 Tubulin, followed by incubation with 568 anti-mouse (cat. # A10037, Life 
Technologies) and 488 anti-rabbit (cat. # A11034, Life Technologies) secondary antibodies, and 
then mounted onto slides with ProLong Diamond (cat. # p36965, Fisher Scientific). 
Microscopy and Image Analysis. Total Internal Reflection Fluorescence Microcopy was 
performed on a Nikon Eclipse Ti (Nikon Instruments Inc., Melville, NY) inverted microscope 
equipped with multiple laser lines with AOTF control, Nikon Perfect Focus System, and an 
environmental chamber supplying 5% CO2 and 37°C temperature control. Samples were imaged 
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with a 100X Apo TIRF 1.49 NA oil-immersion objective. TIRF excitation angle was determined by 
adjusting for maximum extinction. Image acquisition was performed using a Hamamatsu ORCA-
Flash 4.0 V2 cMOS camera (Hamamatsu Photonics). Live images were acquired on a 2 second 
interval for the indicated total duration. Images were deconvolved in NIS Elements using five 
iterations of Richardson-Lucy deconvolution algorithm. Overall microtubule structure and 
acetylation were imaged using a Zeiss Axio Observer 7- ApoTome.2 inverted microscope with 
63X oil-immersion objective and Axiocam 503 mono camera. Microscopy figures and videos were 
prepared using ImageJ/FIJI (36) and Adobe Photoshop. For the quantification of the time courses 
on the effect of insulin on CLASP2 and G2L1 trailing, the live cell images were analyzed using 
Imaris 9.2.1 with FIJI extension. Specifically, +TIP microtubule decoration lengths were measured 
at different time points at fixed intervals with respect to the length of the time course using a frame 
within the first minute. The manual filament tools of Imaris were used for measurement of +TIP 
trail lengths, which were identified by scrubbing the time slider. Measurement was done visually, 
starting at the moving end of the trail or trail break with the AutoPath feature of Imaris. Once all 
visible trails were measured on frame, a new filament object was created and time was scrubbed 
to the next frame along the fixed interval specified earlier. After image analysis was completed, 
all filament objects were compared to the serum-starved length of the first frame using Imaris 
Vantage. +TIP length data was graphed using RStudio. For quantification of +TIP velocity, 
CLASP2 position was tracked during a 30-second imaging interval using the Manual Tracking 
FIJI plug-in. The density of +TIPs was quantified by manually counting motile CLASP2 signal on 
microtubules, and normalizing to cell area. For quantification of tubulin stabilization after 
nocodazole treatment with or without insulin treatment, the length of the microtubule network was 
measured using Simple Neurite Tracer FIJI plug-in (37), and normalized to cell area. 
Quantification for microtubule acetylation was determined using ImageJ corrected total cell 
fluorescence (CTCF) which calculates the normalized fluorescence based on the formula 
(Integrated density – (Area of selected cell x Mean background fluorescence) (38). 
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Experimental Design and Statistical Rationale. Previous interactome experiments using 
the mean and standard deviations for the spectrum counts of proteins identified by SAINT analysis 
as significantly enriched over the negative control showed a sample size of four biological 
replicates per group provided more than sufficient power to detect differences between groups 
(24). Based on the high degree of reproducibility, we used a sample size of two biological 
replicates for the interactome experiments and followed those experiments with confirmatory 
reciprocal interactomes as well as IP and western blots to further validate potential protein 
partners. The varying statistical analyzes for the remainder of the other types of experiments are 
listed in the Figure Legends and were justifiable based upon the data and basic experiment 
performed. For spectral counting measurements, modified peptides, semi-tryptic peptides, and 
shared peptides were included. Statistical analysis of +TIP density, +TIP velocity, and tubulin 
stabilization experiments was performed by confirming the distribution of the data by Shapiro-Wilk 
normality test, and performing a paired or unpaired t-test as indicated. Statistical analysis of CTCF 




Insulin Regulates the Phosphorylation of G2L1, MARK2, CLIP2, EB1, AGAP3, and 
CKAP5 -  We recently reported characterization of a CLASP2 protein network in 3T3-L1 
adipocytes (24), and since we previously detected CLASP2 in an unbiased proteomics screen for 
proteins that undergo insulin-stimulated phosphorylation (11), we hypothesized that the members 
of the CLASP2 network in 3T3-L1 adipocytes (24) also undergo insulin-regulated phosphorylation. 
We adapted our previously reported technique (32-34, 39) of label-free quantification of 
phosphorylation, where extracted ion abundances from parent ion phosphopeptides are 
normalized to parent ion peptides of the same protein, except we now take advantage of 
automated processing of the data using Progenesis (Figure 1A). We validated the quantitative 
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approach via Progenesis using immunoprecipitated CLASP2 digests (Supplemental Figure 1). 
Upon stimulating 3T3-L1 adipocytes with insulin, we discovered that the CLASP2 protein network 
members G2L1, CLIP2, AGAP3, MARK2 and CKAP5 all undergo insulin-regulated 
phosphorylation, as well as EB1, a fundamental +TIP with ties to CLASP2, G2L1, CLIP2 and 
CKAP5 (40) (Figure 1B-C, Supplemental Figure 2, and Supplemental Tables 1-6). These findings 
highlight a completely new series of proteins that are responsive to insulin and reveal the 
existence of a systematic microtubule-regulating protein response to insulin. 
The G2L1 Interactomes -  We previously characterized the CLASP2 protein network in 
3T3-L1 adipocytes and discovered G2L1 was enriched in three alternative, cross-reference 
CLASP2 interactomes  (24). To follow-up on a possible relationship between CLASP2 and G2L1 
in 3T3-L1 adipocytes, we performed multiple G2L1 affinity purification coupled with mass 
spectrometry (AP-MS) experiments using our previously described label-free quantitative 
proteomics approach (24) (Figure 2A). We performed basal versus insulin treatment interactome 
analysis of endogenous G2L1 IPs as well as overexpressed G2L1 immunoprecipitated with two 
alternative antibodies, one to a myc-epitope tag and the other to a mCherry fluorescent protein 
tag (western blots of all G2L1 protein IPs are shown in Figure 2B). The resulting spectrum count 
data for the G2L1 IPs was then scored for enrichment over the various appropriate negative 
control IPs using the established bioinformatic tool Significance Analysis of Interactome (SAINT) 
as previously described (24, 41-43). On the SAINT Probability Score (“P-Score”) scale from 0 to 
1, ≥0.85 was used to signify a protein as “SAINT qualified”. Protein SAINT scores, spectrum 
counts, distinct peptides, and percent protein coverage for the interactomes are included in the 
Supplemental Tables 7-15. We used our Spectrum Count Profile (“SCP”) to hierarchically 
summarize the raw spectral count data of all the SAINT-qualified proteins (Figure 2C) followed by 
Cytoscape-based (44) integration to simultaneously visualize all three G2L1 SAINT-qualified 
interactomes (Figure 2D). All three G2L1 interactomes (Uniprot ID for G2L1 is GA2L1) had SAINT-
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qualified enrichment of CLASP2 and CLIP2, discoveries which serve to reciprocally confirm our 
previous report that both CLASP2 and CLIP2 can co-IP G2L1 (24). G2L1 was identified during a 
proteome-wide screen for EB-binding proteins (26). In our overexpressed G2L1 interactomes, 
EB1 (Uniprot ID: MARE1) and to a lesser extent EB3 (Uniprot ID: MARE3) were both strongly 
enriched, with spectrum count numbers similar to those detected for CLASP2. CLASP2 at a 
predicted mass of ~141kDa has the potential for a larger number of spectrum counts compared 
to EB1 at ~30kDa, so the fact that EB1 and CLASP2 had comparable spectrum counts suggests 
a larger amount of EB1 associates with G2L1 versus CLASP2 (as well as CLIP2). Antibodies 
targeted to endogenous protein can disrupt protein-protein interactions and possess non-specific 
cross-reactivity (45, 46), which may explain why EB1 was undetected in the endogenous G2L1 
interactome. In order to further validate the association between EB1 and G2L1, we performed 
an endogenous EB1 interactome and confirmed the reciprocal co-IP of G2L1 with EB1 
(Supplemental Figure 3). The overexpressed G2L1 interactomes possessed levels of CLASP1 
similar to those detected for CLASP2, EB1, and CLIP2 and contained a lower amount of EB3 as 
compared to EB1. There were other similarities between the two overexpressed G2L1 
interactomes, including the presence of five members (APC1, ANC2/APC2, APC4, APC5, and 
CDC23) of the anaphase promoting complex/cyclosome (APC), an E3 ubiquitin ligase that 
facilitates ubiquitination and degradation of target proteins (47). There were also differences in 
the two overexpressed G2L1 interactomes that may have resulted from steric hindrance caused 
by antibody binding. 
To follow up on the G2L1 interactome findings, we performed traditional co-IP and western 
blot experiments and focused on confirmatory tests for the association of G2L1 together with 
CLASP2, CLIP2, and EB1. We reproduced the interactome data and reciprocally confirmed the 
interactions between G2L1 and CLASP2, CLIP2, and EB1 (Supplemental Figure 4). We also 
found no significant effect of insulin on the reciprocal interactions, findings that are similar to those 
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observed in the interactome studies. Collectively, we have established a new relationship 
between G2L1 and CLASP2, CLIP2, and EB1 in 3T3-L1 adipocytes.   
Colocalization of CLASP2 and G2L1 -   CLASP2 and G2L1 are reciprocally enriched in 
the interactome studies we have performed, evidence that supports potential biological 
cooperation between these two +TIPs. We therefore tested for colocalization of CLASP2 and 
G2L1 in basal state 3T3-L1 adipocytes proximal to the cell membrane using live-cell total internal 
reflection fluorescence microscopy (TIRFM), a powerful tool for visualizing +TIP localization and 
microtubule dynamics. Overexpression of either GFP-CLASP2-HA (Figure 3A) or mCherry-G2L1-
myc (Figure 3B) in 3T3-L1 adipocytes revealed that each protein localizes to the growing plus-
end of microtubules within comet-like structures, which can be observed tracking across the cell 
and leading a newly formed microtubule, per classic +TIP behavior. When co-expressed, CLASP2 
and G2L1 are coincident on dynamic comet-like structures (Video 1). Examination of fixed 
samples of adipocytes co-expressing GFP-CLASP2 and mCherry-G2L1 revealed that 
comparatively, G2L1 occupies a smaller and more proximal area of the +TIP than CLASP2, which 
led a longer comet-like structure on microtubules (Figure 3C). These additional findings validate 
the interactome data and solidify a potential cooperative relationship between CLASP2 and G2L1. 
The Effect of Insulin on CLASP2 and G2L1 +TIP Dynamics -  Upon successfully 
establishing colocalization of CLASP2 and G2L1 with TIRFM in 3T3-L1 adipocytes, as well as 
discovering that both CLASP2 (11) and G2L1 undergo insulin-regulated phosphorylation, we 
profiled the effect of insulin on CLASP2 and G2L1 cellular localization proximal to the inner 
surface of the plasma membrane in a live-cell setting. Microtubule polymerization and density 
have both been shown to increase after insulin treatment in 3T3-L1 adipocytes (28, 29). 
Comparative quantification revealed that insulin increases the number of CLASP2-containing 
+TIPs per unit area (Figure 4A-B), data that aligns with the previous findings that insulin increases 
microtubule density. Conversely, we discovered that insulin treatment reduces the average 
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velocity of CLASP2-containing +TIPs (Figure 4C-D), suggesting that insulin slows the 
polymerization rate of individual microtubules with CLASP2-containing +TIPs. Taken together our 
data aligns with pre-existing findings that insulin increases the population of microtubules. While 
this implicates insulin increases gross microtubule polymerization, we propose that while insulin 
may create more microtubules, microtubules that possess CLASP2-containing +TIPs polymerize 
slower in the presence of insulin. 
Prior to insulin treatment, CLASP2 moves in short, rapid bursts with a comet-like 
appearance per classic +TIP presentation (Video 2). After insulin stimulation, we discovered that 
CLASP2 shifts from being exclusively enriched at the plus-end microtubule tip to “trailing”, in 
which CLASP2 decorates the trailing length of the microtubule proximal to the growing plus-end 
(Video 2, Figure 4E-G, Supplemental Figure 5). Since we observed G2L1 co-localizes with 
CLASP2 in adipocytes, we hypothesized that G2L1 behavior might also respond to insulin 
stimulation. In the basal state G2L1 displays classic +TIP activity (Video 3) whereas insulin 
stimulates G2L1 trailing on microtubules (Video 3, Figure 5A-C, Supplemental Figure 5). Insulin 
is known to stimulate membrane ruffling in adipocytes (4). Since G2L1 is known to localize to 
actin in addition to microtubules, it is of particular interest that upon insulin stimulation, G2L1 
strongly enriches to lamellipodial protrusions (Video 3). Upon testing the effect of insulin on 
adipocytes co-expressing both GFP-CLASP2 and mCherry-G2L1, the insulin-stimulated trailing 
phenotype was definitively captured (Video 4, Figure 6A-C). Quantification of the +TIP trail length 
captured the trailing phenotype induced by insulin within each of the representative adipocytes 
(Figure 4G, Figure 5C and Figure 6C). In order to rule out insulin-stimulated +TIP trailing resulting 
from a phototoxic effect associated with continual exposure to laser light during live cell imaging, 
we have reproduced the findings in cells visualized for only thirty seconds at a time at five-minute 
intervals pre- and post-insulin stimulation (data not shown). The insulin-induced +TIP trailing 
response observed was not universal across all cells, perhaps due to the reported heterogeneous 
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nature of adipocyte differentiation (48). We present here, for the first time, that insulin affects 
CLASP2 and G2L1 +TIP dynamics (modelled in Figure 6D), direct evidence that supports the 
hypothesis that the +TIP network represents a new signaling system associated with insulin 
action. 
Insulin Stimulates -Tubulin Acetylation at Lysine 40 and Microtubule Stabilization -  
Results from the live cell experiments revealed that insulin stimulates CLASP2 and G2L1 to shift 
from predominant localization at the microtubule plus-end to trailing along varied lengths of the 
microtubule lattice proximal to the growing plus-end. Dynamic short-lived microtubules are 
characterized by transient periods of growth and shrinkage (49), although a subset of the 
microtubule population are stabilized and persist for much longer times as a means for long-range 
transport. These long-lived microtubules can possess -tubulin acetylation at lysine 40 (“AcK40”), 
a post-translational modification that protects microtubules from mechanical stress (50, 51). Since 
the microtubules with insulin-stimulated CLASP2 and G2L1 trails visually presented as “brace-
like” across the microtubule lattice, we first tested the hypothesis that insulin stimulates a marker 
for stabilized microtubules, AcK40. Western blot analysis of whole cell lysates from serum-starved 
3T3-L1 adipocytes either left untreated or subjected to an insulin time course confirmed that 
insulin stimulates -tubulin acetylation at lysine 40 (“AcK40”) (Figure 7A), results that were 
reproduced with AcK40 immunofluorescence imaging (Figure 7B-C). Since an insulin-stimulated 
increase in AcK40 is not direct evidence of microtubule stabilization, we tested whether insulin 
treatment results in increased resistance to the microtubule depolymerizing agent, nocodazole. 
Treatment of serum-starved adipocytes with nocodazole induced a loss of microtubules, while 
pre-treatment of cells with insulin reduced the severity of nocodazole-stimulated microtubule 
depolymerization (Figure 7D-E), therefore, we conclude insulin increases the stability of 
microtubules in 3T3-L1 adipocytes. 
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To test for specificity of the AcK40 western blot signal and also to search for the 
pathway(s) involved in regulating insulin-controlled AcK40, we discovered we could inhibit the 
insulin-stimulated increase of AcK40 by treating the adipocytes with the mTOR inhibitor 
rapamycin (32% average decrease, n=7, p ≤ 0.01), implicating mTOR in insulin-stimulated 
microtubule stabilization (Figure 7F). The kinase GSK3 has been linked to suppressing AcK40 in 
the context of cell polarization (10). Since GSK3 is active in the basal state and deactivated by 
insulin, we hypothesized that GSK3 regulates basal levels of microtubule stabilization through 
suppression of AcK40. Treatment of 3T3-L1 adipocytes with the GSK3 inhibitor SB216763 
reversed the decreased levels of AcK40 observed in the basal state, indicating that insulin 
suppresses GSK3 activity in part to encourage an increase in AcK40 (Figure 7G and H). These 
discoveries reveal a whole new property of insulin, namely increased microtubule stabilization as 
well as the stimulation of -tubulin acetylation at lysine 40, a generally accepted marker for 
microtubule stabilization, a mechanism that is regulated at least in part by a counterbalance 
between GSK3 and rapamycin-sensitive mTOR-controlled signaling elements (modelled in Figure 
7I).       
 
DISCUSSION 
We followed up on our recent CLASP2 interactome study by characterizing the G2L1 
interactome within 3T3-L1 adipocytes. The +TIPs have been an encouraging fit for interactome 
studies, as known positive control interaction partners have been routinely detected and 
reciprocal interactomes have been largely confirmatory. We reproduced results from other cell 
lines (23, 26) that G2L1 co-IPs EB1 and discovered that G2L1 also co-IPs both CLASP2 and 
CLIP2 in 3T3-L1 adipocytes, data which reciprocally confirms our previous CLASP2 and CLIP2 
interactome findings (24). We performed an EB1 interactome and confirmed the reciprocal 
presence of G2L1, although, we did not detect significant enrichment of CLASP2 in the EB1 
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interactome. Prior experiments on EB1 and CLASP2 have supported the concept that these two 
proteins may track along growing microtubule plus-ends individually from each other, as was 
observed in PtK1 epithelial cells (52). The lack of a detectable strong co-IP between EB1 and 
CLASP2 in adipocytes is consistent with our previous CLASP2 interactome work (24) although 
discordant from a study in COS-1 cells which proved an interaction can occur between EB1 and 
CLASP2 (17). There have been repeated published links between CLASP2 and the EB proteins, 
including a dependence of EB1 proper microtubule localization on CLASP2 within a multitude of 
cell types (53). All of these observed differences in the relationship between EB1 and CLASP2 
could be explained by cell-line specificity, a transient nature of association as previously proposed 
(17), a difference in the expression levels of other +TIPs necessary for assembling specific protein 
complexes (9, 40, 49, 54-56), a lack of detectable interactions resulting from technical limitations, 
or issues with the immunoprecipitating antibodies (45, 46). Future studies will investigate whether 
the lack of a detectable association between CLASP2 and EB1 indicates that G2L1 and EB1 may 
operate independently of CLASP2 in adipocytes and whether the G2L1/EB1 relationship is 
affected by insulin in a spatio-temporal manner. The link between G2L1 and CLASP2 discovered 
during the interactome studies was solidified by the live-cell TIRFM-based discovery that G2L1 
and CLASP2 co-localize at growing microtubule plus-ends.  In addition to localizing to microtubule 
plus-ends, G2L1 also possesses binding capacity for filamentous actin (F-actin) (23, 57, 58). We 
have unpublished findings indicating that in addition to the insulin-regulated +TIP characteristics 
observed for G2L1 reported here, G2L1 also colocalizes with insulin-stimulated actin 
reorganization and membrane ruffling. In addition, we have now established that both CLASP2 
(11) and G2L1 undergo insulin-stimulated phosphorylation. Since insulin-stimulated actin 
reorganization is paramount for proper insulin action (7), future studies will elucidate whether a 
functional association exists between insulin-stimulated actin dynamics and G2L1.   
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The effect of insulin on both CLASP2 and G2L1 on microtubules proximal to the interior 
surface of the cell (“the TIRFM zone”) represent a new mode of +TIP regulation in the context of 
insulin action. Live-cell TIRFM captured CLASP2 and G2L1 shifting from predominant plus-end 
localization to insulin-stimulated immobilization along the length of the microtubule lattice, 
proximal to the growing plus-end (modelled in Figure 6D). CLASP2 has repeatedly been linked to 
the stabilization of microtubules through participating in microtubule rescue events and preventing 
microtubule depolymerization, across multiple organisms (17, 56, 59-72). These effects are 
imparted through the various domains in CLASP2, for example, the tumor overexpressed gene 2 
(TOG2) domain was recently shown to maintain the integrity of the stabilizing cap localized at the 
growing microtubule tip (70). While this is the first time CLASP2 and G2L1 have been observed 
to shift in real-time after insulin stimulation from predominant plus-end localization to trailing along 
the growing length of the microtubule, it is not the first time an alteration in the spatial relationship 
between CLASP2 and microtubules has been captured. In live migrating Ptk1 epithelial cells, 
within the cell body, CLASP2 displayed typical +TIP action, whereas lamella and lamellipodium-
based CLASP2 lacked +TIP behaviour and instead exhibited trailing via binding along the length 
of the growing microtubule lattice (52), very reminiscent of the effect of insulin we observed. As 
Wittmann and Waterman-Storer stated (52), CLASP2 shifts from true +TIP behaviour to full lattice 
decoration, a style of microtubule association more reminiscent of classic MAP family members 
(8). Hypothetically, these newly created microtubules populated with lattice dispersion of CLASP2 
and G2L1 trails may serve as a signal to assemble or initiate an as-of-yet undetermined molecular 
event, in this case, a signalling signature associated with insulin action. There is noticeable 
heterogeneity in the literature with regards to findings on CLASP2 movement, which can be 
explained in part by the fact that different cell types possess alternative proteomes, and these 
differences probably influence the cooperative nature (49) and resulting behaviour of +TIPs. For 
example, the spatio-temporal changes in CLASP2 reported for wound healing experiments in 
Ptk1 epithelial cells (52) and HaCat keratinocytes (16) were not observed in motile 3T3 fibroblasts, 
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although, when the 3T3 fibroblasts underwent serum stimulation, CLASP2 accumulated and 
immobilized at the leading edge of the cell in yet another pattern of localization (10, 14, 72). These 
different phenotypes are distinct from the population of CLASP2 that has been observed at the 
Golgi (73, 74). So, overall, there is support for a diverse range of CLASP2 regulation and function 
that can be dictated by multiple aspects, including cell-specific needs and intracellular localization.    
This insulin-stimulated +TIP trailing along newly created microtubules possessed what we 
viewed as a “brace-like” appearance, and since prior studies support a microtubule-stabilizing 
role for CLASP2 (10, 69, 70), we hypothesized that insulin stimulates the stabilization of selective 
microtubules. Follow-up studies discovered that insulin stimulates -tubulin Lysine 40 acetylation 
(“AcK40”), a post-translational modification within the 15-nm-wide lumen of the microtubule that 
is associated with stabilization of both long-lived and curved microtubules (50, 51, 75). AcK40 
only occurs on polymerized microtubules (76-79) and is catalysed by the tubulin acetyltransferase 
aTAT1 (80, 81) whereas the exclusively cytoplasmic (82) histone deacetylase 6 (HDAC6) 
deacetylates tubulin (83). AcK40 takes place on polymerized microtubules to reduce structural 
strain by increasing microtubule flexibility (50, 51). These stabilized microtubules, by becoming 
protected against breaking and shrinkage, exist for prolonged periods of time (77, 78, 84). Insulin-
stimulated CLASP2/G2L1 trailing occurred acutely, within minutes of insulin treatment, whereas 
the effect of insulin on microtubule stabilization via AcK40 was gradual, indicating that trailing 
events precede stabilization, although whether a causal relationship exists between +TIP trailing 
and microtubule stabilization is unknown and whether trailing and AcK40 occur on the same 
microtubules will be the subject of future studies. Since the effect of insulin on AcK40 was not 
rapid (as seen with Akt substrates (85)) but was instead delayed and profiled more like the effects 
of insulin observed for mTOR substrates (85), we tested and confirmed that inhibition of mTOR 
with rapamycin blocks insulin-stimulated AcK40. The control of insulin-stimulated AcK40 by 
mTOR was found to be counterbalanced by GSK3-mediated suppression of AcK40 in the basal 
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state. Future studies will be aimed at testing the hypothesis that, through insulin-mediated 
suppression of GSK3 activity and activation of mTOR, insulin influences HDAC6 and aTAT1 
activity to control -tubulin AcK40 (modelled in Figure 7I).  
 Of all of the microtubule-regulating protein interactome studies we have completed thus 
far using the label-free spectrum counting technique we have devised, none of the validated 
network proteins analyzed have exhibited measureable protein abundance changes after insulin-
stimulation. In this report, our traditional co-IP and western blot confirmatory follow-up 
experiments led to findings that agreed with the quantitative proteomics data, the proteins did in 
fact co-IP although the abundance of the co-immunoprecipitated proteins was not reproducibly 
affected by insulin. As an alternative to changes in protein association, we hypothesized that since 
CLASP2 undergoes robust insulin-stimulated phosphorylation (11), perhaps the 3T3-L1 adipocyte 
CLASP2 protein network proteins serve as potential candidates for insulin-regulated 
phosphorylation. We developed a straight-forward approach to quantifying changes in protein 
phosphorylation that incorporated basic immunoprecipitation and in-gel protein digestion 
techniques together with automated label-free quantification of extracted ion abundance 
performed in the software program Progenesis QI for Proteomics. This protein-specific 
quantitative phosphoproteomics approach expanded the number of +TIPs known to undergo 
insulin-regulated phosphorylation from just CLASP2 to a list that now includes CLIP2, G2L1, EB1 
and CKAP5, while we also discovered that the CLASP2 network members MARK2 and AGAP3 
undergo insulin-regulated phosphorylation as well (hypothetically modelled in Figure 1C). Of all 
the sites analyzed, the phosphorylation of CLIP2 (also known as CLIP-115) at Ser552 underwent 
the strongest increase upon insulin treatment. Phosphorylation of CLIP1 (also known as CLIP-
170) at Thr287 and Ser195/Ser1318 has been linked to centrosome duplication and kinetochore-
microtubule attachments (86, 87), respectively, although Ser1318 of CLIP1 is not found in the 
shorter CLIP2 isoform, while Ser552, the insulin-stimulated phosphorylation site of CLIP2, is not 
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conserved in CLIP1. Ser552 lies approximately 300 amino acids past the second microtubule-
binding Cytoskeleton-associated protein Gly-rich (“CAP-Gly”) domain (88) and the surrounding 
serine-rich basic regions within the N-terminus of CLIP2 and is positioned along the extensive 
coiled-coil region of CLIP2 known to mediate CLIP2 dimerization (89). CLIP1 and CLIP2 
association with microtubules has been shown to be regulated by phosphorylation in a negative 
manner (89-91). Phosphorylation also regulates CLIP1 intramolecular association and 
accompanying CLIP1 conformational changes (92). Each of these phospho-regulated events has 
been linked to phosphorylation sites near the CAP-GLY domains and the surrounding serine-rich 
basic regions within the N-terminus of the CLIPs, rendering the insulin-stimulated Ser552 CLIP2 
phosphorylation site with the potential to be functionally distinct. The CLASP2 interactome project 
revealed a novel association between the +TIP CLIP2 and the GTPase-activating proteins 
AGAP1 and AGAP3 (24).  There is a key difference between the CLASP2/G2L1 interaction and 
the proposed complex between CLIP2 and the AGAPs, in that the AGAPs are the lone protein 
members of the CLASP2 network in 3T3-L1 adipocytes that act as both a GTPase (93, 94) and a 
GTPase activating protein (95, 96). In addition, the AGAPs also contain a Pleckstrin Homology 
(“PH”) domain, whose known functions include mediating protein-protein interactions as well as 
membrane localization through the binding of phosphoinositides (97). Of the insulin-stimulated 
AGAP3 phosphorylation sites we have discovered, one is within the GTPase domain (pSer300) 
while the other is located within the PH domain (pSer478). CLIP2 was the most enriched protein 
in the AGAP3 interactome (24), supportive of the hypothesis that functional cooperativity exists 
between CLIP2 and AGAP3 in the context of insulin action. 
EB1, known as “the master integrator of +TIP networks” (49) as well as CKAP5 
(alternatively referred to as ch‐TOG) (56, 98), also undergo insulin-regulated phosphorylation. 
EB1, like CLASP2, G2L1, and CLIP2, tracks growing microtubule plus-ends and acts as an 
integrating scaffold protein that promotes a wide variety of +TIP localization to the growing 
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microtubule plus-end (99). Phosphorylation of EB proteins is known to regulate microtubule 
dynamics and EB function in a variety of organisms and biological systems (100-109). The insulin-
stimulated EB1 phosphorylation site we detected, Ser155, lies in the coiled-coil linker region of 
EB1 that bridges the N-terminal Calponin-homology (CH) domain to the C-terminal EB homology 
(EBH) domain and adjacent EEY/F motif.  Ser155 of EB1 already has a possible connection with 
major players in insulin action, as AKT and GSK3 regulate levels of Ser155 phosphorylation to 
control EB1 localization to microtubule plus-ends (110).  CKAP5 is a member of the XMAP215 
family of microtubule polymerases that catalyzes the addition of tubulin dimers to elongating 
microtubule plus-ends. CKAP5 localizes to the extreme tip of the growing microtubule plus end 
whereas EB1 is further down the microtubule (111), so in an in vitro model for example, EB1 is 
located tens of nanometers further down the microtubule from CKAP5 (112). CKAP5 consists of 
five successive TOG domains that span across the majority of this 225kDa protein while a 
microtubule lattice binding domain is located between the fourth and fifth TOG domains, all of 
which participate in the processive addition of tubulin dimers to the growing microtubule plus end 
(113, 114). Within the CKAP5 C-terminus lies both a cryptic TOG domain as well as a shorter four 
-helix-based domain (with no known identity) that mediates protein-protein interactions (115, 
116). It is within this terminal multi--helix-containing domain where insulin significantly affects 
the phosphorylation of CKAP5 at Ser1861 in a suppressive manner. We discovered a stretch of 
CKAP5 phosphorylation sites spanning amino acids 1800-1870 that also trend towards insulin-
mediated suppression of phosphorylation (Supplemental Figure 2F), although the four biological 
replicates analysed did not achieve statistical significance. With CKAP5 playing such a vital role 
in cytoskeletal management, it is of future interest to elucidate the significance of insulin-mediated 
changes in CKAP5 phosphorylation within the context of insulin-controlled microtubule dynamics.  
Another protein we discovered to undergo insulin-regulated phosphorylation was the only 
kinase of the group, MARK2 (also known as Par-1b). Classical MAPs bind and release along the 
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microtubule lattice as a mode of microtubule regulation, a process that is controlled in part by 
transient MAP phosphorylation by the MARK family kinases (reviewed in (8)). MARK2-mediated 
release of the various MAPs from the microtubule lattice affects the stabilization of microtubules, 
microtubule polymerization, microtubule bundling, the association between microtubules and 
actin, and microtubule mediated motor transport of intracellular cargo (8). Insulin stimulates an 
increase in the phosphorylation of MARK2 at Ser40, Thr42 and Ser43, a short stretch of residues 
that lies adjacent to the MARK2 kinase domain, while phosphorylation within the spacer region of 
MARK2 at Ser568 undergoes insulin-mediated suppression. MARK2 makes an intriguing 
hypothetical candidate kinase for insulin regulation since so many MAPs are under MARK2 
control and MAPs are a critical component for fine-tuning microtubule dynamics.     
The novel findings we present significantly expand the number of known +TIPs affected 
by insulin form a new hypothesis that a network of proteins linked to microtubule regulation 
synergize to coordinate insulin-regulated MT dynamics. Upon initial investigation of the effect of 
insulin on two of these network proteins, CLASP2 and G2L1, we discovered +TIP trailing, a new 
mode of insulin-regulated protein behaviour. Follow-up studies determined that insulin stimulates 
-tubulin Lysine 40 acetylation, a discovery that led to the finding that insulin increases 
microtubule stabilization. Taken together, we have expanded the protein systems and cytoskeletal 
elements involved in insulin action, information that is paramount for developing future studies 
aimed at understanding and identifying underlying mechanisms of insulin resistance, a hallmark 
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Figure 1. G2L1, MARK2, CLIP2, EB1, AGAP3, and CKAP5 undergo insulin-regulated 
phosphorylation. A, Serum-starved 3T3-L1 adipocytes were either left untreated or treated with 
insulin, lysed, and target proteins were immunoprecipitated as described in Experimental 
Procedures. The IPs were separated by SDS-PAGE and the gel slice corresponding to the protein 
of interest was excised and subjected to trypsin digestion. The resulting tryptic digest was purified 
and subsequently analyzed by tandem mass spectrometry. Raw data processing for quantification 
was executed in Progeneis QI for Proteomics and peptide/protein identification was performed by 
database searching with Mascot. The resulting Mascot peptide and protein identifications were 
imported into Progenesis QI for Proteomics and quantification of changes in phosphopeptide 
abundance was performed via extracted ion abundance in Progenesis QI for Proteomics. MS/MS, 
tandem mass spectrometry. B, G2L1, MARK2, CLIP2, EB1, AGAP3, and CKAP5 phosphorylation 
was analyzed as described above and in Experimental Procedures (n=4 per protein). 
Phosphopeptides are labeled with both the starting and final amino acid position of the 
phosphopeptide within the protein, along with the phospho-site (in red). The basal versus insulin 
data is separated by the vertical dashed black line. The horizontal red dashed line represents a 
50% decrease in phosphorylation while the horizontal green dashed line represents a 2-fold 
increase in phosphorylation. *p≤0.05; **p≤0.01 insulin compared to basal; T-test. BAS, basal. INS, 
insulin. C, The illustration depicts all identified phosphorylation sites affected by insulin, the 
location of the phosphorylation sites within each protein, the effect of insulin on phosphorylation 
(increased = green, suppressed = red), as well as the hypothetical localization of the microtubule-
regulating proteins respective to the microtubule. TOG, tumor overexpressed gene; UBA, 
ubiquitin-associated; GAR, Gas2-related; GAP, GTPase-activating protein; KA1, kinase 
associated domain 1; ANK, ankyrin; EEY/F, EEY/F motif; GLD, GTP-binding protein-like domain; 
EBH, EB homology; PH, pleckstrin homology. 
46 
 
Figure 2. The G2L1 interactomes. A, To identify new interacting partners for G2L1 in 3T3-L1 
adipocytes, different G2L1 IPs were compared against negative control IPs either in the absence 
or presence of insulin treatment. The IPs were separated by SDS-PAGE, fractionated into gel 
slices, subjected to trypsin digestion, and analyzed by tandem mass spectrometry. Peptide and 
protein identification was performed by Mascot database searching, and the resulting spectral 
count data was assembled with Scaffold. The spectrum count data was then scored for 
enrichment using SAINT and the resulting SAINT-qualified protein spectral count data was 
visualized with a Spectrum Count Profile “SCP”. The SAINT-qualified proteins from the three 
alternative G2L1 interactomes performed were then integrated and visualized with Cytoscape. B, 
150mm plates of differentiated 3T3-L1 adipocytes either left untreated or infected with mCherry-
G2L1-myc overexpressing adenovirus and were lysed in an isotonic CHAPS lysis buffer. IPs were 
performed as described in Experimental Procedures. The IPs or whole cell lysates were resolved 
by 10% SDS-PAGE and transferred to nitrocellulose membranes. The membranes containing the 
immunoprecipitated proteins were subjected to western blot with the antibodies indicated. The 
labels on the right side of the blot indicate where the various proteins migrate on the gel. MK, 
protein ladder marker; WB, western blot; WCL, whole cell lysates; MS/MS tandem mass 
spectrometry. C, For the various G2L1 interactomes (from top to bottom, endogenous G2L1, 
mCherry-G2L1-myc, and mCherry-G2L1-myc), the “SAINT-qualified” proteins were ordered in a 
hierarchical manner, from lowest spectrum counts identified to highest, and results from two 
experiments were individually plotted in a SCP. Basal NIgG IPs (green), insulin NIgG IPs 
(magenta), basal G2L1 IPs (red), and insulin G2L1 IPs (turquoise). D, Cytoscape-based 
integrated visual representation of the anti-G2L1, anti-myc mCherry-G2L1-myc, and anti-mCherry 
mCherry-G2L1-myc SAINT-qualified proteins. The proteins listed in turquoise were identified in 
all three G2L1 interactomes, while the proteins listed in green were shared between the anti-
mCherry and anti-myc antibody mCherry-G2L1-myc interactomes. 
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Figure 3. CLASP2 and G2L1 colocalize in 3T3-L1 adipocytes. A-B, Live-cell imaging of 
adipocytes cultured in complete media co-expressing mRuby2-Tubulin (magenta) and GFP-
CLASP2-HA (A, green) or mCherry-G2L1-myc (B, green). Live cells were imaged using TIRFM 
on a 2-second acquisition interval. Time series images to the right of the whole cell image are 
used to highlight +TIP dynamics within the indicated ROI. C, Immunofluorescence images of 
adipocytes cultured in complete media co-overexpressing GFP-CLASP2-HA (green) and 
mCherry-G2L1-myc (magenta). Cells were fixed and immunolabeled for tubulin (inverted white). 
Bottom row is magnified ROI. ROI, region of interest. Scale bar = 20m. 
Figure 4. The effect of insulin on CLASP2 +TIP dynamics. Live-cell imaging of adipocytes 
serum-starved for one hour and subsequently stimulated with 100nM insulin. Live cells were 
imaged using TIRFM on a two-second acquisition interval. A, Single frame of live-cell imaging of 
adipocytes co-expressing GFP-CLASP2 (green) and mRuby2-Tubulin (magenta) at basal state 
(top row) or ten minutes (bottom row) following insulin stimulation. CLASP2 is displayed in 
inverted white to highlight +TIP density. B, Quantification of CLASP2-containing +TIP density per 
unit area (m2) in adipocytes at basal state or ten minutes following insulin stimulation. Percent 
increase in CLASP2-containing +TIP density is indicated to the right. Statistical comparison made 
by paired parametric t-test, n = 5 cells. C, Temporally color-coded projection of GFP-CLASP2 
localization during a 30 second live-cell imaging interval. The length and extent of color overlap 
of time-projected CLASP2 localization indicates reduced displacement and hence lower velocity 
of CLASP2-containing +TIPs during the imaging interval in adipocytes after ten minutes of insulin 
stimulation. D, Quantification of CLASP2-containing +TIP velocity in adipocytes at basal state or 
ten minutes following insulin stimulation indicates reduced velocity of CLASP2-containing +TIPS 
after insulin treatment. Statistical comparison made by unpaired parametric t-test, n = 123-125 
CLASP2-containing +TIPS from five cells. Scale bars = 5m. E, Image of entire cells in the basal 
state (left panel) or eight minutes post insulin treatment (right panel) extracted from Video 2. Time 
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series images under the whole cell image are used to highlight insulin-stimulated +TIP dynamics 
within the indicated ROI. F, Time series extracted from Video 2 of the indicated ROIs at either the 
basal state or at four minutes post insulin treatment to present an example of changing CLASP2 
microtubule plus-end dynamics with insulin stimulation. G, Live cell CLASP2-containing +TIP 
dynamics of the ROI extracted from Video 2 were captured in the basal state followed by 
stimulation with insulin. Each insulin-stimulated CLASP2-containing +TIP trail length time point 
was compared against the basal CLASP2-containing +TIP trail length to test for significant 
differences. T-test; *p≤0.05, **p≤0.01. Red circles represent outlier data points. ROI, region of 
interest. BAS, basal. INS, insulin. Scale bar = 10m. 
Figure 5. Insulin stimulates G2L1 plus-end trailing. Live-cell imaging of adipocytes 
overexpressing mCherry-G2L1-myc (magenta). Adipocytes were serum starved for one hour and 
subsequently stimulated with 100nM insulin. Live cells were imaged using TIRFM on a two-
second acquisition interval and the displayed time series were extracted from Video 3. A, Image 
of entire cell in the basal state (left panel) or twelve minutes post insulin treatment (right panel). 
Time series images under the whole cell image are used to highlight insulin-stimulated G2L1-
containing +TIP dynamics within the indicated ROI. B, Time series of the indicated ROIs at either 
the basal state or at four minutes post insulin treatment to present an example of changing G2L1 
plus-end dynamics with insulin stimulation. C, Live cell G2L1-containing +TIP dynamics of the 
ROI were captured in the basal state followed by stimulation with insulin. Each insulin-stimulated 
G2L1-containing +TIP trail length time point was compared against the basal G2L1-containing 
+TIP trail length to test for significant differences. T-test; *p≤0.05, **p≤0.01. Red circles represent 
outlier data points. ROI, region of interest. BAS, basal. INS, insulin. Scale bar = 10m.  
Figure 6. Insulin stimulates CLASP2 and G2L1 microtubule plus-end co-trailing. Live-cell 
imaging of adipocytes co-overexpressing GFP-CLASP2-HA (green) and mCherry-G2L1-myc 
(magenta). Adipocytes were serum starved for one hour and subsequently stimulated with 100nM 
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insulin. Live cells were imaged using TIRFM on a two-second acquisition interval and the 
displayed time series were extracted from Video 4. A, Image of entire cell in the basal state (left 
panel) or eight minutes post insulin treatment (right panel). Time series images under the whole 
cell image are used to highlight insulin-stimulated +TIP dynamics within the indicated ROI. B, 
Time series of the indicated ROIs at either the basal state or at three minutes post insulin 
treatment to present an example of changing CLASP2 and G2L1 plus-end dynamics with insulin 
stimulation. C, Live cell +TIP dynamics of the ROI were captured in the basal state followed by 
stimulation with insulin. Each insulin-stimulated +TIP trail length time point was compared against 
the basal +TIP trail length to test for significant differences. T-test; *p≤0.05, **p≤0.01. Red circles 
represent outlier data points. ROI, region of interest. BAS, basal. INS, insulin. Scale bar = 10m. 
D, A model depicting the insulin-stimulated shift of CLASP2 and G2L1 from growing plus-end 
microtubule localization to “trailing”, a behavior characterized by CLASP2 and G2L1 decorating 
the trailing microtubule lattice behind the growing microtubule plus-end. 
Figure 7. Insulin stimulates acetylation of -tubulin at Lysine 40 and microtubule 
stabilization. A, Serum-starved 3T3-L1 adipocytes were either left untreated or treated with an 
insulin time course for the times indicated. Adipocyte lysis was performed as described in 
Experimental Procedures. The whole cell lysates were resolved by 10% SDS-PAGE and 
transferred to nitrocellulose membranes. The membranes were subjected to western blot with the 
antibodies indicated. Representative blot, n=3. MK, protein ladder marker. AcK40, -tubulin 
acetylation at lysine 40. B, Immunofluorescence images of the effect of insulin (30min, 100nM) 
on serum-starved adipocytes. Cells were fixed and immunolabeled for -tubulin (white) and 
AcK40 (inverted white). Scale bar = 10m. C, Quantification of AcK40 in adipocytes at basal state 
or ten minutes following insulin stimulation indicates increased AcK40 after insulin treatment. The 
images were quantified for corrected total cell fluorescence (CTCF) as described in Experimental 
Procedures. Quantification was based on data collected from 25-40 cells per condition. The 
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images are representative of five independent experiments. Error bars represent ±SEM and 
statistical comparison was made by unpaired parametric t-test. D, Immunofluorescence images 
of the effect of insulin (30min) on nocodazole-induced microtubule depolymerization in serum-
starved adipocytes. Cells were left untreated or treated with either 2M nocodazole alone for 
15min or 100nM insulin for 30 min followed by 2M nocodazole for 15min, fixed and 
immunolabeled for -tubulin (inverted white). CTRL, control, NOCO, nocodazole. INS, insulin. 
Scale bar = 10m. E, Quantification of microtubule density in adipocytes indicates insulin 
treatment results in resistance to nocodazole-induced microtubule depolymerization. 
Quantification was based on data collected from 8-11 cells per condition. The images are 
representative of two independent experiments. Error bars represent ±SEM and statistical 
comparison was made by unpaired parametric t-test. F, Serum-starved 3T3-L1 adipocytes were 
either left untreated or treated with either insulin alone or insulin together with rapamycin 
pretreatment to inhibit mTOR. Evaluation of AcK40 was performed as described above in A. G, 
Serum-starved 3T3-L1 adipocytes were either left untreated, treated with SB216763 alone (a 
GSK3 inhibitor), treated with insulin alone, or treated with insulin together with SB216763 
pretreatment. Evaluation of AcK40 was performed as described above in A. H, Six experiments 
as performed in G were quantified by densitometry to evaluate the effects of SB216763-mediated 
inhibition of GSK3 on AcK40. The AcK40 signal was normalized to the total -tubulin signal on 
the western blots. These values were then normalized by the mean value of the basal sample 
and then expressed as a fold change over basal ±SEM; T-test. SB, SB216763. I, In this proposed 
hypothetical model, GSK3 suppresses the acetylation of -tubulin at lysine 40 (“AcK40”) in the 
basal state. Insulin deactivates GSK3 and stimulates AcK40 through rapamycin-sensitive mTOR. 
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